Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
Oncotarget|November 10, 2016
Inhibition of Chk1 with the small molecule inhibitor V158411 induces DNA damage and cell death in an unperturbed S-phaseJoanne Wayne, Teresa Brooks, Andrew J MasseyDNA Repair|March 19, 2021
Chk1 inhibition induces a DNA damage bystander effect in cocultured tumour cellsTeresa Brooks, Joanne Wayne, Andrew J MasseyMolecular Biomedicine|January 10, 2022
Checkpoint Kinase 1 (Chk1) inhibition fails to activate the Stimulator of Interferon Genes (STING) innate immune signalling in a human coculture cancer systemTeresa Brooks, Joanne Wayne, Andrew J MasseyMolecular Cancer|June 11, 2014
Inhibition of the checkpoint kinase Chk1 induces DNA damage and cell death in human Leukemia and Lymphoma cellsChristopher Bryant, Kirsten Scriven, Andrew J MasseyThe FEBS Journal|February 2, 2021
Targeting DNA damage response pathways to activate the STING innate immune signaling pathway in human cancer cellsJoanne Wayne, Teresa Brooks, Alexandra Landras, et al.Journal of Cellular and Molecular Medicine|October 28, 2021
Targeting DYRK1A/B kinases to modulate p21-cyclin D1-p27 signalling and induce anti-tumour activity in a model of human glioblastomaAndrew J Massey, Karen Benwell, Mike Burbridge, et al.Plos One|October 27, 2010
Context-dependent cell cycle checkpoint abrogation by a novel kinase inhibitorAndrew J Massey, Jenifer Borgognoni, Carol Bentley, et al.Molecular Oncology|October 17, 2015
mTORC1 and DNA-PKcs as novel molecular determinants of sensitivity to Chk1 inhibitionAndrew J Massey, Peter Stephens, Rebecca Rawlinson, et al.Oncotarget|October 6, 2015
Identification of novel, in vivo active Chk1 inhibitors utilizing structure guided drug designAndrew J Massey, Stephen Stokes, Helen Browne, et al.Scientific Reports|October 25, 2023
The GPCR adaptor protein Norbin regulates S1PR1 trafficking and the morphology, cell cycle and survival of PC12 cellsValdemar B I Johansen, Elizabeth Hampson, Elpida Tsonou, et al.Pageof 3